Usutu Virus Infections Found among Austrian Blood Donors
|
By LabMedica International staff writers Posted on 24 Oct 2017 |

Image: The cobas 8800 fully integrated and automated system for sample preparation and real-time polymerase chain reactions (Photo courtesy of Roche).
Usutu virus (USUV) is an African mosquito-borne flavivirus belonging to the Japanese encephalitis virus serocomplex. USUV is closely related to Murray Valley encephalitis virus, Japanese encephalitis virus, and West Nile virus (WNV).
Besides wild birds, humans can also be infected with Usutu virus through mosquito bites. Usually human Usutu virus infections are asymptomatic though occasionally they may result in fever and rash. Neurologic symptoms and severe courses of the disease are rare in humans, although critical illness was reported in immunosuppressed patients.
European scientists led by those at the University of Veterinary Medicine (Vienna, Austria) collected samples of all blood donations collected from June 1, 2017 onwards by the Blood Service for Austrian Red Cross during the ongoing WNV transmission season 2017 and were sent to the German Red Cross, Blood Service for Baden-Württemberg-Hessen. In Germany they were screened in minipools of 19 samples using the automated nucleic acid (NAT) test on the cobas 8800 system.
The investigators reported that as of October 11, 2017, a total of seven of 12,047 blood donations collected between July 24 and August 25, 2017, reacted positive. WNV NAT-screening positive samples were retested by WNV- and Usutu virus (USUV)-specific reverse transcription (RT) - and quantitative reverse transcription polymerase chain (RT-qPCR) assays as well as by conventional RT-PCR tests amplifying a wide range of flaviviruses. While one blood donation was confirmed as containing WNV nucleic acid, the six others were negative by WNV-specific RT-qPCR, but positive by USUV-specific RT-qPCR.
The authors concluded that although USUV is a potential human pathogen, there are no specific regulations on screening blood donations for this virus. According to the general rules, only clinically healthy people are allowed to donate blood. However, the USUV-positive blood donors did not show any symptoms before and after donation. They propose that extension of flavivirus screening of blood donations might be taken into consideration by USUV-endemic European countries.
In order to raise awareness and allow timely actions, they intentionally wrote this paper at this point in time when the WNV and USUV transmission seasons are still ongoing, which, depending on weather conditions, may last in central Europe until the end of October. The study was published in the October 2017 edition of the journal Eurosurveillance.
Related Links:
University of Veterinary Medicine
Besides wild birds, humans can also be infected with Usutu virus through mosquito bites. Usually human Usutu virus infections are asymptomatic though occasionally they may result in fever and rash. Neurologic symptoms and severe courses of the disease are rare in humans, although critical illness was reported in immunosuppressed patients.
European scientists led by those at the University of Veterinary Medicine (Vienna, Austria) collected samples of all blood donations collected from June 1, 2017 onwards by the Blood Service for Austrian Red Cross during the ongoing WNV transmission season 2017 and were sent to the German Red Cross, Blood Service for Baden-Württemberg-Hessen. In Germany they were screened in minipools of 19 samples using the automated nucleic acid (NAT) test on the cobas 8800 system.
The investigators reported that as of October 11, 2017, a total of seven of 12,047 blood donations collected between July 24 and August 25, 2017, reacted positive. WNV NAT-screening positive samples were retested by WNV- and Usutu virus (USUV)-specific reverse transcription (RT) - and quantitative reverse transcription polymerase chain (RT-qPCR) assays as well as by conventional RT-PCR tests amplifying a wide range of flaviviruses. While one blood donation was confirmed as containing WNV nucleic acid, the six others were negative by WNV-specific RT-qPCR, but positive by USUV-specific RT-qPCR.
The authors concluded that although USUV is a potential human pathogen, there are no specific regulations on screening blood donations for this virus. According to the general rules, only clinically healthy people are allowed to donate blood. However, the USUV-positive blood donors did not show any symptoms before and after donation. They propose that extension of flavivirus screening of blood donations might be taken into consideration by USUV-endemic European countries.
In order to raise awareness and allow timely actions, they intentionally wrote this paper at this point in time when the WNV and USUV transmission seasons are still ongoing, which, depending on weather conditions, may last in central Europe until the end of October. The study was published in the October 2017 edition of the journal Eurosurveillance.
Related Links:
University of Veterinary Medicine
Latest Microbiology News
- Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease
- AI-Powered Platform Enables Rapid Detection of Drug-Resistant C. Auris Pathogens
- New Test Measures How Effectively Antibiotics Kill Bacteria
- New Antimicrobial Stewardship Standards for TB Care to Optimize Diagnostics
- New UTI Diagnosis Method Delivers Antibiotic Resistance Results 24 Hours Earlier
- Breakthroughs in Microbial Analysis to Enhance Disease Prediction
- Blood-Based Diagnostic Method Could Identify Pediatric LRTIs
- Rapid Diagnostic Test Matches Gold Standard for Sepsis Detection
- Rapid POC Tuberculosis Test Provides Results Within 15 Minutes
- Rapid Assay Identifies Bloodstream Infection Pathogens Directly from Patient Samples
- Blood-Based Molecular Signatures to Enable Rapid EPTB Diagnosis
- 15-Minute Blood Test Diagnoses Life-Threatening Infections in Children
- High-Throughput Enteric Panels Detect Multiple GI Bacterial Infections from Single Stool Swab Sample
- Fast Noninvasive Bedside Test Uses Sugar Fingerprint to Detect Fungal Infections
- Rapid Sepsis Diagnostic Device to Enable Personalized Critical Care for ICU Patients
- Microfluidic Platform Assesses Neutrophil Function in Sepsis Patients
Channels
Clinical Chemistry
view channel
New PSA-Based Prognostic Model Improves Prostate Cancer Risk Assessment
Prostate cancer is the second-leading cause of cancer death among American men, and about one in eight will be diagnosed in their lifetime. Screening relies on blood levels of prostate-specific antigen... Read more
Extracellular Vesicles Linked to Heart Failure Risk in CKD Patients
Chronic kidney disease (CKD) affects more than 1 in 7 Americans and is strongly associated with cardiovascular complications, which account for more than half of deaths among people with CKD.... Read moreMolecular Diagnostics
view channel
Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test
Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more
Blood Test Detects Early-Stage Cancers by Measuring Epigenetic Instability
Early-stage cancers are notoriously difficult to detect because molecular changes are subtle and often missed by existing screening tools. Many liquid biopsies rely on measuring absolute DNA methylation... Read more
“Lab-On-A-Disc” Device Paves Way for More Automated Liquid Biopsies
Extracellular vesicles (EVs) are tiny particles released by cells into the bloodstream that carry molecular information about a cell’s condition, including whether it is cancerous. However, EVs are highly... Read more
Blood Test Identifies Inflammatory Breast Cancer Patients at Increased Risk of Brain Metastasis
Brain metastasis is a frequent and devastating complication in patients with inflammatory breast cancer, an aggressive subtype with limited treatment options. Despite its high incidence, the biological... Read moreImmunology
view channelBlood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug
Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more
Whole-Genome Sequencing Approach Identifies Cancer Patients Benefitting From PARP-Inhibitor Treatment
Targeted cancer therapies such as PARP inhibitors can be highly effective, but only for patients whose tumors carry specific DNA repair defects. Identifying these patients accurately remains challenging,... Read more
Ultrasensitive Liquid Biopsy Demonstrates Efficacy in Predicting Immunotherapy Response
Immunotherapy has transformed cancer treatment, but only a small proportion of patients experience lasting benefit, with response rates often remaining between 10% and 20%. Clinicians currently lack reliable... Read moreMicrobiology
view channel
Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease
Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read moreAI-Powered Platform Enables Rapid Detection of Drug-Resistant C. Auris Pathogens
Infections caused by the pathogenic yeast Candida auris pose a significant threat to hospitalized patients, particularly those with weakened immune systems or those who have invasive medical devices.... Read morePathology
view channel
Engineered Yeast Cells Enable Rapid Testing of Cancer Immunotherapy
Developing new cancer immunotherapies is a slow, costly, and high-risk process, particularly for CAR T cell treatments that must precisely recognize cancer-specific antigens. Small differences in tumor... Read more
First-Of-Its-Kind Test Identifies Autism Risk at Birth
Autism spectrum disorder is treatable, and extensive research shows that early intervention can significantly improve cognitive, social, and behavioral outcomes. Yet in the United States, the average age... Read moreTechnology
view channel
Robotic Technology Unveiled for Automated Diagnostic Blood Draws
Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more
ADLM Launches First-of-Its-Kind Data Science Program for Laboratory Medicine Professionals
Clinical laboratories generate billions of test results each year, creating a treasure trove of data with the potential to support more personalized testing, improve operational efficiency, and enhance patient care.... Read moreAptamer Biosensor Technology to Transform Virus Detection
Rapid and reliable virus detection is essential for controlling outbreaks, from seasonal influenza to global pandemics such as COVID-19. Conventional diagnostic methods, including cell culture, antigen... Read more
AI Models Could Predict Pre-Eclampsia and Anemia Earlier Using Routine Blood Tests
Pre-eclampsia and anemia are major contributors to maternal and child mortality worldwide, together accounting for more than half a million deaths each year and leaving millions with long-term health complications.... Read moreIndustry
view channelNew Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing
Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
AI-Powered Cervical Cancer Test Set for Major Rollout in Latin America
Noul Co., a Korean company specializing in AI-based blood and cancer diagnostics, announced it will supply its intelligence (AI)-based miLab CER cervical cancer diagnostic solution to Mexico under a multi‑year... Read more
Diasorin and Fisher Scientific Enter into US Distribution Agreement for Molecular POC Platform
Diasorin (Saluggia, Italy) has entered into an exclusive distribution agreement with Fisher Scientific, part of Thermo Fisher Scientific (Waltham, MA, USA), for the LIAISON NES molecular point-of-care... Read more







